Exploratory Study on the Safety and Tolerability of Novel Circular RNA-HM2002 Injected Epicardially During Coronary Artery Bypass Grafting in Ischemic Heart Failure Patients
Latest Information Update: 10 Oct 2024
At a glance
- Drugs HM 2002 (Primary)
- Indications Heart failure
- Focus Adverse reactions
- 10 Oct 2024 New trial record